Drugs / Stem Cell Educator-Treated Mononuclear Cells Apheresis
Stem Cell Educator-Treated Mononuclear Cells Apheresis
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04299152 | Nov 2021 → Apr 2022 | severe acute respiratory syndrome | Throne Biotechnologies Inc. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stem Cell Educator-Treated Mononuclear Cells Apheresis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04299152 ↗ |
| Modality | Cell therapy | “SCE therapy uses human multipotent cord blood stem cells (CB-SC) from human cord blood.” NCT04299152 ↗ |
| Route | Intravenous | “followed by an infusion intravenously back to the patient” NCT04299152 ↗ |